Affordable Oral Contraception to Middle Income in Developing Countries

A partnership promoting affordable contraception to middle income women in developing countries.

Bayer Schering Pharma

The Bayer Schering Pharma (BSP) Contraceptive Security Initiative seeks to address the ever increasing need for access to an affordable contraceptive in the developing world while recognizing the ever decreasing amount of donor funding available. As the first ever project of this nature, BSP will register, market and promote Microgynon Fe, an oral contraceptive, at an affordable price to middle income women in multiple developing countries on a continuous and permanent basis. BSP will seek to create a permanent market niche for Microgynon Fe as a “tier 2” product. As such, Microgynon Fe will have a price point above the social marketing and public sector level and below commercial prices, thus insuring its sustainability beyond USAID funding. As a long-term commitment to USAID, BSP has committed to maintaining this price point over time.


  • United States Agency for International Development (USAID)

    Funding Agencies
    United States | Staff size: Unknown

    USAID is the lead U.S. Government agency that works to end extreme global poverty and enable resilient, democratic societies to realize their potential.

    U.S. foreign assistance has...

  • Bayer HealthCare Pharmacuticals

    Institute, Goods Supplier
    United States | Staff size: 10,000+

    Bayer HealthCare Pharmaceuticals is the pharmaceutical division of Bayer HealthCare AG. It markets products in more than 100 countries and in 2011 the company generated sales of almost...

More Resources

Key Information

  • Start Date 2009
  • End Date 2014
  • ValueUSD 60.9 Million